Latest in News & Research

Does Dupilumab Provide Sustained Control of Atopic Dermatitis?

Dupilumab can help patients achieve adequate disease control and reduce use of other therapies
By Dermsquared Editorial Team | | December 15, 2021

COVID-19 Severity Does Not Differ for Patients With Skin Conditions

Acute COVID-19 and its treatment can impact the course of skin disease in vitiligo, psoriasis, atopic dermatitis, chronic urticaria
By Physician’s Briefing Staff | | December 15, 2021

Report Highlights Characteristics of Omicron SARS-CoV-2 Variant in U.S.

Fourteen of the first 43 cases reported international travel during the 14 days preceding symptom onset or positive test result
By Physician’s Briefing Staff | | December 14, 2021

Omicron Resists Pfizer Vaccine but Causes Less Severe Disease

Risk for hospital admission among adults with COVID-19 29 percent lower than in the first pandemic wave that began in March 2020
By Physician’s Briefing Staff | | December 14, 2021

Adjuvant Dupilumab Improves Asthma Control for Children

Adding dupilumab versus placebo reduced exacerbations, improved lung function in children with uncontrolled moderate-to-severe asthma
By Physician’s Briefing Staff | | December 09, 2021

Topical Tapinarof Reduces Severity of Plaque Psoriasis

Response rate higher but more adverse events seen at week 12 in patients with plaque psoriasis receiving tapinarof versus vehicle control
By Physician’s Briefing Staff | | December 09, 2021

What Are the Consequences of Delay in MMS for Keratinocyte Carcinoma?

22 percent of patients who had delay to MMS due to stay-at-home order were more worried about their cancer
By Dermsquared Editorial Team | | December 08, 2021

Generalized Pustular Psoriasis Is Rare, Has Variable Treatment

More than 20 therapies were tried in a case series of 95 patients; 19 percent reported hospitalization during follow-up
By Dermsquared Editorial Team | | December 08, 2021

Treatments Explored for Moderate-to-Severe Alopecia Areata

Improvement in lesional scalp transcriptome toward nonlesional profile seen at week 24 for both ritlecitinib, brepocitinib
By Physician’s Briefing Staff | | December 08, 2021

Psoriasis Ups Risk for Vascular Disease, Venous Thromboembolism

Risk particularly high in women and individuals with psoriatic arthritis
By Physician’s Briefing Staff | | December 07, 2021

Spatial Clustering of Exemptions Linked to Measles Outbreaks

Increases in medical exemptions result in more than twice as many infections than if exemptions were maintained at pre-policy change level
By Physician’s Briefing Staff | | December 06, 2021

Telemedicine Visits Do Not Lead to More Follow-Up Care

However, telemedicine visits associated with fewer medication prescriptions, orders for laboratory tests or imaging
By Physician’s Briefing Staff | | December 03, 2021

Recommendations Developed for Dermatology Artificial Intelligence

Checklist for evaluation of image-based AI reports grouped into topics of data, technique, technical assessment, application
By Dermsquared Editorial Team | | December 01, 2021

Is BF-200 ALA Superior to Vehicle for Total Lesion Clearance in AK?

BF-200 ALA has high efficacy, excellent cosmetic outcome for patients with mild-to-severe actinic keratoses located on extremities, trunk, neck
By Dermsquared Editorial Team | | December 01, 2021

Giving Nivolumab/Ipilimumab First Ups Overall Survival in Melanoma

Two-year overall survival 72 percent for those starting with N/I, 52 percent for those starting with dabrafenib/trametinib
By Physician's Briefing Staff | | December 01, 2021

Old Spice, Secret Antiperspirants Recalled Due to Benzene

Proctor & Gamble said that it has not received any reports of harm from the recalled products
By Robert Preidt (HealthDay News) | | November 30, 2021

Colorectal Cancer Risk Up for Patients With Psoriasis

In subgroup analysis according to sex, increased risk for CRC seen for female, but not male psoriasis patients
By Physician’s Briefing Staff | | November 30, 2021

Vaccine Makers Already Testing Their Shots Against Omicron Variant

So far, existing vaccines have proven effective against prior coronavirus variants, including the delta variant
By Robin Foster and Robert Preidt (HealthDay News) | | November 29, 2021

Personal Care Product-Related Contact Dermatitis Increasing

Men twice as likely to have soaps as source of PCP, while hair care products were twice as likely to be a source among...
By Dermsquared Editorial Team | | November 24, 2021

Is Patient-Led Surveillance Feasible After Localized Melanoma?

Patient-led surveillance correlated with increased skin self-examination frequency, had no adverse impact on psychological outcomes
By Dermsquared Editorial Team | | November 24, 2021

Pandemic Had Greater Effect on Work-Life Balance for Female Physicians

A sizable gender gap evident for risk of depression and anxiety
By Physician’s Briefing Staff | | November 24, 2021

Risk for Psoriasis Reduced After Tonsillectomy

Among patients with rheumatoid arthritis, the risk for psoriasis was increased after tonsillectomy
By Physician’s Briefing Staff | | November 24, 2021

Atopic Dermatitis Linked to Shorter Stature in Early Childhood

Associations of atopic dermatitis with height and BMI decreased by age 14 and 5.5 years, respectively
By Physician’s Briefing Staff | | November 18, 2021

24 of 1200

Headline from the Week of February 09 - 15, 2026

Second Annual National Cancer Database Report Presented for 2022

By Elana Gotkine (HealthDay News) | | February 11, 2026

Presurgical Pembrolizumab Beneficial for Desmoplastic Melanoma

By Elana Gotkine (HealthDay News) | | February 11, 2026